Placebo of intravenous L-citrulline

DRUG2 trials

Sponsors

Asklepion Pharmaceuticals, LLC

Conditions

Atrial Septal DefectAtrioventricular Septal DefectHeart Defects, CongenitalHypertension, PulmonaryVentricular Septal Defect

Phase 1

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol

CompletedNCT01120964

Asklepion Pharmaceuticals, LLCAtrial Septal Defect, Atrioventricular Septal Defect, Ventricular Septal Defect

Start: 2010-09-30End: 2012-04-30Updated: 2022-07-27

Phase 3

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery

CompletedNCT00335244

Asklepion Pharmaceuticals, LLCHeart Defects, Congenital, Hypertension, Pulmonary

Start: 2006-05-31End: 2009-12-31Updated: 2015-02-02